19 May 2013
Keywords: kalypsys, complete, ph, ia, study, kd3010, drug
Article | 02 October 2006
US drug discovery and development company Kalypsys has initiated and expects to complete a Phase Ia clinical trial of KD3010, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 October 2006
25 September 2006
17 May 2013
© 2013 thepharmaletter.com